Tcr2 Therapeutics Inc (TCRR) Return on Assets ROA from the first quarter of 2023 to first quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Tcr2 Therapeutics Inc   (NASDAQ: TCRR)


Tcr2 Therapeutics Inc 's ROA from the first quarter of 2023 to the first quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Tcr2 Therapeutics Inc 's ROA in the first quarter of 2023?
Tcr2 Therapeutics Inc recorded a cumulative net loss of $-163 million during 12 months ending in the first quarter of 2023, resulting in a negative return on assets (ROA) of -69.56%.

However, within the Healthcare sector 875 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2023 quarter, so far to 4975, from total ROA ranking in the fourth quarter of 2022 at 5561.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Total Assets Change -53.31 % -35.51 % -21.51 % -16.28 % -18.45 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -163 -152 -119 -115 -107
Return On Assets (TTM) -69.56 % -54.71 % -38.89 % -35.33 % -31.62 %
TCRR's Total Ranking # 4975 # 5561 # 4675 # 4795 # 4665
Total Assets (TTM) in million 151 208 271 308 323
Seq. Total Assets Change -27.41 % -23.37 % -11.97 % -4.65 % 0.27 %
Seq. Net Income Change - - - - -

TCRR's 5 Years Annual ROA >> Back to TCRR Management Effectiveness >> Compare TCRR ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 145
Sector # 876
Overall # 4869

Return On Assets Statistics
High Average Low
-4.06 %
-33.48 %
-69.35 %
(Mar 31 2019)   (Mar 31 2023)





Financial Statements
Tcr2 Therapeutics Inc 's Assets $ 151 million TCRR's Balance sheet
Tcr2 Therapeutics Inc 's Income $ -40 million Quarterly TCRR's Income Statement
TCRR's Income by Division See TCRR's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019
FY
Y / Y Total Assets Change -35.51 % 30.87 % 46.09 % - -
Total Assets in million 208 322 246 169 0
Y / Y Net Income Change - - - - -
Net Income in million -152 -100 -67 -48 0
Annual Return On Assets -73.07 % -30.98 % -27.26 % -28.24 % -

TCRR's 5 Years Annual ROA >> Back to TCRR Management Effectiveness >> Compare TCRR ROA to its Competitors



More Return On Assets Ratios
TCRR's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
TCRR's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for TCRR's Competitors
Subscribers only: Roa for Tcr2 Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for TCRR's Customers

You may also want to know
TCRR's Roi TCRR's Inventory Turnover Ratio TCRR's Growth Rates TCRR's Dividend Comparisons
TCRR's Profitability Ratios TCRR's Asset Turnover Ratio TCRR's Dividend Growth
TCRR's Roe TCRR's Valuation Ratios TCRR's Financial Strength Ratios TCRR's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2023, within Healthcare Sector ROA

Date modified: 2026-08-29T17:40:50+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.